Drug pricing bills introduced in House and Senate

Apr 22, 2021 - 02:24 PM
REMA-legislation-introduced

House Energy and Commerce Committee Chairman Frank Pallone Jr., D-NJ, today re-introduced the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) with other Democratic committee leaders.

The legislation would authorize the Health and Human Services Secretary to negotiate Medicare prescription drug prices; cap beneficiary out-of-pocket spending for prescription drugs at $2,000 per year; require drug makers that increase prices faster than inflation to pay a rebate to the federal government; and invest anticipated savings in federal programs to develop treatments and address the opioid crisis.

Yesterday, House Republican committee leaders introduced the Lower Cost, More Cures Act (H.R. 19), also intended to lower drug costs. View a summary here.

In addition, Sens. Dick Durbin, D-Ill., and Rob Portman, R-Ohio, introduced AHA-supported legislation that would reduce spending on discarded medications that are the result of excessively large, single-use drug vials. The Recovering Excessive Funds for Unused and Needless Drugs (REFUND) Act would enable Medicare to recoup money from drug companies that are paid for wasted medications, and provide savings to seniors enrolled in Medicare.

 

Related News Articles

Headline
AHA responds to Medicare $2 Drug List Model request for information
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
AHA issues statement on the 2024 election
"The AHA and America’s hospitals and health systems congratulate President-elect Trump and look forward to working with him and his incoming Administration to…
Headline
Senate report scrutinizes Medicare Advantage prior authorization denials for post-acute care services 
A report released Oct. 17 by the Senate Homeland Security Committee’s investigative subcommittee scrutinizes some of the nation's largest Medicare Advantage…
Headline
CMS releases RFI, sample list of prescription drugs that may be included under proposed Medicare $2 Drug List Model 
The Centers for Medicare & Medicaid Services Oct. 9 released a request for information and a sample list of prescription drugs it intends to include under…
Headline
Reminder: CMS hosting webinar Oct. 21 on price transparency machine-readable file 2025 requirements 
The Centers for Medicare & Medicaid Services Oct. 21 will host a webinar on meeting its new hospital price transparency requirements becoming effective Jan…
Headline
HHS issues final guidance for second cycle of drug price negotiations 
The Department of Health and Human Services Oct. 2 released final guidance detailing the process for the second cycle of negotiations under the Medicare Drug…